These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3998782)

  • 1. Phase II study of recombinant alpha-2 interferon in resistant multiple myeloma.
    Costanzi JJ; Cooper MR; Scarffe JH; Ozer H; Grubbs SS; Ferraresi RW; Pollard RB; Spiegel RJ
    J Clin Oncol; 1985 May; 3(5):654-9. PubMed ID: 3998782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of interferon in the treatment of multiple myeloma.
    Costanzi JJ; Pollard RB
    Semin Oncol; 1987 Jun; 14(2 Suppl 2):24-8. PubMed ID: 3296211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of rDNA alpha-2 interferon (INTRON A) in patients with multiple myeloma utilizing an escalating induction phase.
    Case DC; Sonneborn HL; Paul SD; Hiebel J; Boyd MA; Shepp MA; Dorsk BM; Bonnem E
    Cancer Treat Rep; 1986 Nov; 70(11):1251-4. PubMed ID: 3768870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferons in the treatment of multiple myeloma.
    Cooper MR; Welander CE
    Cancer; 1987 Feb; 59(3 Suppl):594-600. PubMed ID: 3802025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I-II trial on natural beta interferon in chemoresistant and relapsing multiple myeloma.
    Liberati AM; Cinieri S; Senatore MG; Portuesi MG; De Angelis V; Di Clemente F; Schippa M; Ferrajoli A; Arzano S; Berruto P
    Haematologica; 1990; 75(5):436-42. PubMed ID: 2129033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of rDNA human alpha-2 interferon in multiple myeloma.
    Wagstaff J; Loynds P; Scarffe JH
    Cancer Treat Rep; 1985 May; 69(5):495-8. PubMed ID: 4005872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy.
    Mandelli F; Avvisati G; Amadori S; Boccadoro M; Gernone A; Lauta VM; Marmont F; Petrucci MT; Tribalto M; Vegna ML
    N Engl J Med; 1990 May; 322(20):1430-4. PubMed ID: 2184356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of multiple myeloma with recombinant human leukocyte A interferon.
    Ohno R; Kimura K; Amaki I; Imamura Y; Masaoka T; Miyazaki T; Yoshida Y; Miura Y; Maekawa T; Oguro M
    Cancer Treat Rep; 1985 Dec; 69(12):1433-5. PubMed ID: 4075317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interferon therapy in multiple myeloma].
    Ludwig H; Scheithauer W; Kührer I; Kuzmits R; Gisslinger G; Linkesch W; Zielinski C; Fritz E
    Onkologie; 1988 Aug; 11(4):192-6. PubMed ID: 3054670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of human lymphoblastoid interferon in patients with multiple myeloma.
    Cox EB; Laszlo J; Krown S; Mintzer D; Sarna G
    J Biol Response Mod; 1988 Jun; 7(3):318-25. PubMed ID: 3392554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collaborative phase I-II study of recombinant DNA-produced leukocyte interferon (clone A) in metastatic breast cancer, malignant lymphoma, and multiple myeloma.
    Quesada JR; Hawkins M; Horning S; Alexanian R; Borden E; Merigan T; Adams F; Gutterman JU
    Am J Med; 1984 Sep; 77(3):427-32. PubMed ID: 6548079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-alpha-2b with VMCP for induction in multiple myeloma: the Israel Myeloma Cooperative Group experience.
    Cohen AM; Meytes D; Many A; Brenner B; Aghai E; Shaklai M; Kaufman S; Shtalrid M; Attias D; Manor Y
    Isr J Med Sci; 1995 Oct; 31(10):604-10. PubMed ID: 7591683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferons in the management of multiple myeloma.
    Cooper MR
    Semin Oncol; 1988 Oct; 15(5 Suppl 5):21-5. PubMed ID: 3057642
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment with recombinant interferon-alpha-2C: multiple myeloma and thrombocythaemia in myeloproliferative diseases.
    Ludwig H; Cortelezzi A; Van Camp BG; Polli E; Scheithauer W; Kuzmits R; Linkesch W; Gisslinger H; Sinzinger H; Fritz E
    Oncology; 1985; 42 Suppl 1():19-25. PubMed ID: 4080297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant alpha-interferon as salvage therapy in multiple myeloma. A pilot study.
    Jacobs P; Le Roux IM; Wood L; King HS
    S Afr Med J; 1989 Aug; 76(3):100-2. PubMed ID: 2762938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-2-interferon/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trial.
    Cooper MR; Fefer A; Thompson J; Case DC; Kempf R; Sacher R; Neefe J; Bickers J; Scarffe JH; Spiegel R
    Cancer Treat Rep; 1986 Apr; 70(4):473-6. PubMed ID: 3698041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I/II study of idarubicin, dexamethasone and interferon-alpha (I-Dexa) in patients with relapsed or refractory multiple myeloma.
    Hübel K; Tesch H; Kröger B; Schnell R; Borchmann P; Diehl V; Engert A
    Leukemia; 1997 Dec; 11 Suppl 5():S47-51. PubMed ID: 9436939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of multiple myeloma with high-dose chemotherapy and transplantation of autologous hematopoietic stem cells and subsequent maintenance therapy with interferon alfa-2b or interferon alfa 2b and dexamethasone. Report of the ongoing study of the "4W" Czech Myeloma Group].
    Adam Z; Krejcí M; Bacovský J; Hejlová N; Kuca B; Svojgrová M; Franková H; Gumulec J; Janca J; Veprek K; Januska B; Lehanka F; Rezek Z; Praskac P; Cahová S; Vránová M; Papajík T; Králová E; Novotná J; Scudla V; Koza V; Drbal J; Faber E; Mareschová I; Hájek R
    Vnitr Lek; 1998 Jul; 44(7):400-8. PubMed ID: 9748876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I study of a combination of recombinant interferon-alpha and recombinant interferon-gamma in cancer patients.
    Kurzrock R; Rosenblum MG; Quesada JR; Sherwin SA; Itri LM; Gutterman JU
    J Clin Oncol; 1986 Nov; 4(11):1677-83. PubMed ID: 3095504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mature results of MM-011: a phase I/II trial of liposomal doxorubicin, vincristine, dexamethasone, and lenalidomide combination therapy followed by lenalidomide maintenance for relapsed/refractory multiple myeloma.
    Lazaryan A; Hussein MA; Reu FJ; Faiman B; Habecker B; Ann Karam M; Reed J; Hamilton K; Waksman J; Bruening K; Srkalovic G; Andresen S; Kalaycio M; Sweetenham JW; Sobecks R; Dean R; Knight R; Zeldis JB; Baz R
    Am J Hematol; 2014 Apr; 89(4):349-54. PubMed ID: 24273135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.